Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providersInternal Medicine Physician in Birmingham, AL
NPI: 1184712911Primary Practice Location
Summit Internal Medicine
3570 Grandview Pkwy, Birmingham, AL
Primary Employer
Summit Internal Medicine
summitinternalmedicine.com
HQ Phone
Get M.D. David's Phone Numberphone_androidMobile
Get M.D. David's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardAL State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99213Established patient office or other outpatient visit, typically 15 minutes | 357 | 762 |
| 2 | G0439Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 272 | 272 |
| 3 | 71046X-ray of chest, 2 views | 178 | 198 |
| 4 | 83036Hemoglobin A1C level | 150 | 250 |
| 5 | 93000Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 126 | 131 |
Authors: Zhang, Wei, Glaze, Jeffrey H, Wynne, David
Journal: CEN Case Rep
Publication Date: 2018-02-01
Nesidioblastosis: an uncommon complication seen post Roux-en-Y gastric bypass.
Authors: Jacob Greenspan, Elizabeth Ennis
Journal: Endocrinol Diabetes Metab Case Rep
Publication Date: 2022-12-01
Amiodarone-Induced Epididymitis: A Case Report and Review of the Literature.
Authors: Lyon, Blake A, Wynne, David
Journal: Cureus
Publication Date: 2024-06-21
Lead Sponsor: Exact Sciences Corporation
Intervention / Treatment: DIAGNOSTIC_TEST: FIT test, PROCEDURE: Colonoscopy, DIAGNOSTIC_TEST: mt-sDNA 2.0 screening test
Lead Sponsor: Exact Sciences Corporation
Intervention / Treatment: OTHER: Blood Sample Collection
Lead Sponsor: Eli Lilly and Company
Intervention / Treatment: DRUG: Placebo IV, DRUG: Vedolizumab IV, DRUG: Placebo SC, DRUG: Mirikizumab SC, DRUG: Mirikizumab IV
